Our High Quality (HQ) offering adopts features of Cobra’s GMP manufacture with a 6 week delivery time. HQ plasmid can be used as an ancillary or starting material for the clinical manufacture of immuno-oncology therapies, for example in AAV, lentiviral vector and CRISPR products.
Current standard offerings for HQ supply are from 50mg to 500mg of purified plasmid; this can be tailored to meet specific customer requirements.
HQ production is performed in a Class 2 segregated laboratory using HQ production cell banks as starting material. The HQ grade plasmids are released with a Certificate of Testing and QA TSE Certification.